These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29409924)
21. Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases. Li P; Li Q; Huang Z; Chen W; Lu Y; Tian M Int Forum Allergy Rhinol; 2014 Oct; 4(10):796-801. PubMed ID: 25145986 [TBL] [Abstract][Full Text] [Related]
22. The influence of sublingual immunotherapy on several parameters of immunological response in children suffering from atopic asthma and allergic rhinitis depending on asthma features. Ciepiela O; Zawadzka-Krajewska A; Kotuła I; Demkow U Pneumonol Alergol Pol; 2014; 82(6):503-10. PubMed ID: 25339560 [TBL] [Abstract][Full Text] [Related]
23. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis. Devillier P; Wahn U; Zielen S; Heinrich J Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507 [TBL] [Abstract][Full Text] [Related]
24. High-dose sublingual immunotherapy in patients with uncontrolled allergic rhinitis sensitized to pollen: a real-life clinical study. Irani C; Saleh RA; Jammal M; Haddad F Int Forum Allergy Rhinol; 2014 Oct; 4(10):802-7. PubMed ID: 25224283 [TBL] [Abstract][Full Text] [Related]
25. Allergy and immunology. Assa'ad A Pediatr Ann; 2014 Aug; 43(8):312. PubMed ID: 25102485 [No Abstract] [Full Text] [Related]
26. Pros and cons: Should allergen immunotherapy be considered in all patients with allergic asthma? Gerth van Wijk R; Dahl R Allergy; 2022 Mar; 77(3):1070-1072. PubMed ID: 34608654 [No Abstract] [Full Text] [Related]
27. Sublingual or subcutaneous immunotherapy for allergic rhinitis? Durham SR; Penagos M J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719 [TBL] [Abstract][Full Text] [Related]
29. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases. Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977 [TBL] [Abstract][Full Text] [Related]
30. A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting. Björstad Å; Cardell LO; Hahn-Pedersen J; Svärd M Clin Drug Investig; 2017 Jun; 37(6):541-549. PubMed ID: 28326466 [TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland. Brüggenjürgen B; Reinhold T J Med Econ; 2018 Apr; 21(4):374-381. PubMed ID: 29271271 [TBL] [Abstract][Full Text] [Related]
32. Does evidence support the use of cat allergen immunotherapy? Dhami S; Agarwal A Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462 [TBL] [Abstract][Full Text] [Related]
33. Sublingual immunotherapy in children. Tortajada-Girbés M; Rivas-Juesas C Allergol Immunopathol (Madr); 2018; 46(2):105-106. PubMed ID: 29458988 [No Abstract] [Full Text] [Related]
34. Predictors of quality of life improvement in allergic rhinitis patients after sublingual immunotherapy. Katotomichelakis M; Riga M; Tripsianis G; Balatsouras D; Kourousis C; Danielides G; Giotakis E; Danielides V Ann Otol Rhinol Laryngol; 2015 Jun; 124(6):430-6. PubMed ID: 25539660 [TBL] [Abstract][Full Text] [Related]
35. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial. Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762 [TBL] [Abstract][Full Text] [Related]
36. Perception and practice of sublingual immunotherapy among practicing allergists in the United States: A follow-up survey. Sivam A; Tankersley M; Ann Allergy Asthma Immunol; 2019 Jun; 122(6):623-629.e2. PubMed ID: 30946915 [TBL] [Abstract][Full Text] [Related]
37. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber. Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947 [TBL] [Abstract][Full Text] [Related]